Sotac Pharmaceuticals Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Sharadkumar Patel
Chief executive officer
₹4.8m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 2yrs |
| CEO ownership | 13.1% |
| Management average tenure | 5.5yrs |
| Board average tenure | 9yrs |
Recent management updates
Recent updates
Here's Why We Think Sotac Pharmaceuticals (NSE:SOTAC) Is Well Worth Watching
Sep 28
We Think Sotac Pharmaceuticals (NSE:SOTAC) Is Taking Some Risk With Its Debt
Jul 24Sotac Pharmaceuticals Limited's (NSE:SOTAC) 31% Price Boost Is Out Of Tune With Earnings
Jun 28Sotac Pharmaceuticals Limited (NSE:SOTAC) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected
Feb 29CEO
Sharadkumar Patel (45 yo)
2yrs
Tenure
₹4,800,000
Compensation
Mr. Sharadkumar Dashrathbhai Patel is MD & Chairman of Sotac Pharmaceuticals Private Limited from December 12, 2022 and serves as Director since December 18, 2015. He serves as a Director of Sotac Healthca...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Chairman | 2yrs | ₹4.80m | 13.11% ₹ 158.7m | |
| Whole Time Director | 9yrs | ₹4.80m | 13.11% ₹ 158.7m | |
| Executive Director | 9yrs | ₹4.80m | 9.83% ₹ 119.0m | |
| Executive Director | 9yrs | ₹4.80m | 13.11% ₹ 158.7m | |
| Chief Financial Officer | 2yrs | no data | no data | |
| Company Secretary & Compliance Officer | 1.3yrs | no data | no data |
5.5yrs
Average Tenure
43yo
Average Age
Experienced Management: SOTAC's management team is seasoned and experienced (5.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Chairman | 9yrs | ₹4.80m | 13.11% ₹ 158.7m | |
| Whole Time Director | 9yrs | ₹4.80m | 13.11% ₹ 158.7m | |
| Executive Director | 9yrs | ₹4.80m | 9.83% ₹ 119.0m | |
| Executive Director | 9yrs | ₹4.80m | 13.11% ₹ 158.7m | |
| Independent Director | 2yrs | no data | no data | |
| Additional Non-Executive Independent Director | less than a year | no data | no data | |
| Additional Non-Executive Independent Director | less than a year | no data | no data |
9.0yrs
Average Tenure
39yo
Average Age
Experienced Board: SOTAC's board of directors are considered experienced (9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 22:02 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Sotac Pharmaceuticals Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|